bioMérieux United Kingdom & Ireland
Published on bioMérieux United Kingdom & Ireland (https://www.biomerieux.co.uk)

Home > VIDAS® Lyme panel

All products for:ImmunoassayInfectious Diseases
  • VIDAS® Lyme panel

VIDAS® Lyme panel

Differential diagnosis of Lyme Borreliosis

The combined use of the automated VIDAS® Lyme IgM and VIDAS® Lyme IgG assays will help you provide patients with reliable, differential diagnosis of Lyme borreliosis in just 27 minutes.

  • Clear-cut results
  • High specificity and sensitivity
  • Specific detection of IgG antibodies to Borrelia burgdorferi sensu lato (sl) and in cerebro-spinal fluid (CSF) samples, to aid in the diagnosis of Neuroborreliosis*
Add to my selection

Do you need more information

Contact us
  • OVERVIEW
  • TECHNICAL DETAILS
  • RESOURCES

Transmitted through the bite of infected ticks, Lyme Borreliosis is the most common and rapidly spreading tick-borne disease in the world. However many of the symptoms can also occur with other diseases. VIDAS® Lyme IgM and VIDAS® Lyme IgG allow accurate, rapid, differential diagnosis to avoid misdiagnosis and help prevent progression of the disease towards severe and disabling neurological, cutaneous or articular manifestations.

Clear-cut serological profile

  • Separate IgG and IgM results to facilitate classification of Lyme Borreliosis as early or late/chronic, active or immune
  • Helps ensure patients receive rapid, optimized treatment depending on their stage of infection
  • Easy result interpretation:
    • No equivocal zone for VIDAS Lyme IgG results
    • Avoids unnecessary patient anxiety and limits additional testing

vidas-lyme-graph1.jpg

Detection of immunological response following a bite from a tick infected with Borrelia burgdorferi

Detection of immunological response following a bite from a tick
infected with Borrelia burgdorferi

 

High specificity and sensitivity*

  • The tests use innovative recombinant chimeric proteins* (VlsE, DbpA, OspC), allowing detection of all main pathogenic Borrelia strains
  • Less rework and confirmatory tests
  • Low level of cross-reaction with syphilis and other infectious diseases*
  • Only patients with Lyme Borreliosis are treated

vidas-lyme-graph.jpg

High specificity and sensitivity

 

* See package inserts for more details

** Performance on serum samples, for references outside US and Canada

*** 17 samples were tested with VIDAS Lyme IgG only and were not taken into account in the VIDAS Lyme IgM sensitivity analysis

 

Cost-effectiveness and streamlined workflow

VIDAS® Lyme IgM and VIDAS® Lyme IgG are performed on the VIDAS® automated immunoanalyzers, appreciated worldwide for their simplicity, flexibility and accuracy.

Key benefits:

  • Ease-of-use
  • Rapid results: only 27 minutes
  • Protocol compatibility between both tests
  • Single-dose format
  • Calibration only once every 28 days

 

 

  VIDAS® Lyme IgM VIDAS® Lyme IgG
Reference 30 319* 30 320*
Tests / kit 60 60
Time to result 27 minutes 27 minutes
Sample type Plasma, Serum Plasma, Serum, CSF*
Sample volume 100 µl 100 µl
Calibration frequency Every 28 days Every 28 days

* For references outside US and Canada only

Find more technical details on resourcecenter.biomerieux.com.

Consult your local bioMérieux representative for product availability in your country.

 

Related Publications

  • Usefulness of quantitative IgG assays Borrelia VLSE LIAISON® and the new VIDAS® Lyme for serological follow-up of patients with Lyme borreliosis
    O. Péter, R. Lienhard, R. Vonlanthen, A. Bonnet-Pierroz, C. Béguelin, A. Schaller, D. Genne (Switzerland)
    Poster | ECCMID 2014

     
  • Performance evaluation of the new VIDAS Lyme IgM and IgG assays compared to the previous VIDAS Lyme total antibodies assay on fresh prospective sera
    S. Neifer, O. Wankmüller (Germany)
    Poster | ECCMID 2012

     
  • Evaluation of two automated tests on the VIDAS® system to detect anti-Lyme disease antibodies IgG and IgM in human serum, plasma and CSF
    G. Bouchard, O. Péter, A. Bonnet-Pierroz, R. Vonlanthen, P. Cosin, N. Ammour, A. M. Brevet, P. Broquedis, N. Dehainault, C. Perret, B. Inçaurgarat (France, Switzerland)
    Poster | ECCMID 2010

Useful Links

  • ESCMID Study Group for Lyme Borreliosis - ESGBOR

  • Centers for Disease Control and Prevention | Resources for Clinicians

 

Find more scientific and educational resources on resourcecenter.biomerieux.com.

 

COMPLETE YOUR SOLUTION

  • VIDAS® EBV panel

    Diagnosis of Infectious Mononucleosis

  • VIDAS® ToRC panel

    Serenity throughout pregnancy

  • mini VIDAS®

    Compact multiparametric immunoanalyzer

  • VIDAS® 3

    New immunoanalyzer with full traceability and automation